Results 21 to 30 of about 4,921,476 (300)

Variation in the use of chemotherapy in lung cancer. [PDF]

open access: yes, 2007
Factors influencing the use of chemotherapy for the initial (6 months) treatment of lung cancer in South East England were investigated. The variables explored as possibly influencing the use of chemotherapy were sex, age, the year of diagnosis, the type
Moller, H; id_orcid   +12 more
core   +1 more source

Lung Cancer [PDF]

open access: yesActa Oncologica, 1996
This synthesis of the literature on radiotherapy for lung cancer is based on 80 scientific articles, including 2 meta-analyses, 29 randomized studies, 19 prospective studies, and 21 retrospective studies. These studies involve 28172 patients. Basic treatment for limited-stage small cell lung cancer (SCLC), is chemotherapy.
openaire   +2 more sources

Lung cancer incidence and survival in different ethnic groups in South East England. [PDF]

open access: yes, 2011
BACKGROUND: This study aimed to examine the incidence and survival of lung cancer patients from several different ethnic groups in a large ethnically diverse population in the United Kingdom.
Davies, E. A.; id_orcid   +8 more
core   +1 more source

Primary chondroma of posterior mediastinum with Horner’s syndrome: a case report

open access: yesWorld Journal of Surgical Oncology, 2018
Background Chondroma is a slowly growing, benign cartilaginous tumor which predominantly occurs in long bones of the hands and feet. Primary mediastinal chondroma is rare, especially with Horner’s syndrome.
Xiaoqian Xu   +5 more
doaj   +1 more source

Lung cancer [PDF]

open access: yesBreathe, 2016
While smoking tobacco is linked to more than 80% of all lung cancer cases, many people that have never smoked or been exposed to passive smoke develop lung cancer.
openaire   +4 more sources

Erratum: Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression

open access: yesChinese Journal of Lung Cancer, 2023
Erratum: Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression Guo JJ, Mu D, Yu WW, et al. Zhongguo Fei Ai Za Zhi, 2023, 26(2): 105-112.
Editorial Office of Chinese Journal of Lung Cancer
doaj   +1 more source

Palliative Care in Lung Cancer

open access: yes, 2021
The Lung cancer rate in all cancer types is 21% in men and 5 % in women in European Union Countries. Smoking is the most important factor of lung cancer etiology [1]. The rate of Turkey is found 63% in men and 14% in women in 1988.
Dincer, Selcuk, Ozyalcin, Suleyman
core   +1 more source

Lung Cancer

open access: yesThe Oncologist, 2001
Abstract Is any one combination therapy for metastatic non-small cell lung cancer (NSCLC) superior to other regimens for metastatic NSCLC? The answer is “probably no.” More than 4,000 patients with advanced NSCLC participated in randomized trials presented at the 37th Annual Meeting of the American Society of Clinical Oncology.
T L, Evans, T J, Lynch
openaire   +4 more sources

A retrospective stenting study on superior vena cava syndrome caused by lung cancer

open access: yesThoracic Cancer, 2020
Background Superior vena cava syndrome (SVCS) is a common condition predominantly caused by lung cancer. The presence of symptoms of SVCS, such as elevated intracranial pressure and laryngeal edema, indicates an unfavorable prognosis for lung cancer ...
Sen Wei   +8 more
doaj   +1 more source

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance

open access: yesThoracic Cancer, 2021
Background: Acquired resistance of chemotherapy, especially cisplatin, is a major challenge in lung cancer treatment. We conducted this study to examine whether a cyclin D kinase 4/6 (CDK4/6) inhibitor, PD 0332991, could reverse cisplatin resistance in ...
Minghui Liu   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy